US Patent Issued to Ventana Medical Systems, The Francis Crick Institute, The Royal Marsden NHS Foundation Trust on July 28 for "Personalized ctDNA disease monitoring via representative DNA sequencing" (British, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,546, issued on July 28, was assigned to Ventana Medical Systems Inc. (Tucson, Ariz.), The Francis Crick Institute Ltd. (London) and The Royal Marsden NHS Foundation Trust (London).

"Personalized ctDNA disease monitoring via representative DNA sequencing" was invented by Nelson R. Alexander (Marana, Ariz.), Kevin Richard Litchfield (London), Stacey Stanislaw (Tucson, Ariz.) and Samra Turajlic (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a method of deriving a plurality of genetic variants from a homogenized input sample. Also disclosed herein are methods of identifying a plurality of genetic variants in a sample comprisi...